Cognition Therapeutics (CGTX) Other Working Capital Changes (2020 - 2026)

Cognition Therapeutics (CGTX) has reported Other Working Capital Changes for 7 consecutive years, with -$346000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Working Capital Changes rose 23.62% year-over-year to -$346000.0 in Q2 2026; TTM through Jun 2026 was -$1.0 million, a 15.44% increase from a year earlier, with the FY2025 full-year figure at -$1.2 million, up 28.17% from the prior year.
• Other Working Capital Changes was -$346000.0 for Q2 2026 at Cognition Therapeutics, down from -$136000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $1.1 million in Q1 2022 and troughed at -$890000.0 in Q4 2023.
• A 5-year average of -$213222.2 and a median of -$278000.0 in 2023 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes soared 491.67% in 2022 and plunged 909.72% in 2024, its largest moves.
• Over 5 years, Other Working Capital Changes stood at -$175000.0 in 2022, then slumped by 408.57% to -$890000.0 in 2023, then soared by 92.81% to -$64000.0 in 2024, then sank by 639.06% to -$473000.0 in 2025, then rose by 26.85% to -$346000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$346000.0 (Q2 2026), -$136000.0 (Q1 2026), and -$473000.0 (Q4 2025), per Business Quant data.